Related Experiment Video
Updated: Mar 10, 2026
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Do different organ involvements cause different comorbidity profiles in Behçet's syndrome?
Bahar Özdemir Ulusoy1, Esra Kayacan Erdoğan2, Berkan Armağan2
1Department of Rheumatology, Ankara Gaziler Physical Therapy and Rehabilitation Training and Research Hospital, Ankara, Türkiye.
Objective:
This study investigated whether different organ involvements in Behçet's syndrome (BS) are associated with distinct comorbidity profiles.
Materials And Methods:
A retrospective cohort study was conducted using records of 345 patients who met the 1990 International Study Group criteria for BS. Patients were categorized into three groups based on organ involvement: Vascular (n = 102), Mucocutaneous (n = 94), and 'Others' (n = 149). Data on comorbidities and treatments were collected, and statistical analyses were performed to compare comorbidity frequencies across the groups. Binomial logistic regression was used to examine the relationship between comorbidity profiles and involvement groups.
Results:
The Mucocutaneous group had the lowest comorbidity rate at 37.2%, while the Vascular group showed the highest rate at 59.8%, with a significant increase in cardiovascular comorbidities such as coronary artery disease and stroke. No significant differences were found in Diabetes Mellitus (DM), hyperlipidemia (HL), or hypertension (HT) between groups. Coronary artery disease and stroke were categorized as 'cardiovascular disease (CVD).' Logistic regression showed that vascular involvement independently predicted CVD, even when adjusted for HT, DM, and HL.
Conclusion:
Vascular involvement in BS is associated with a higher burden of cardiovascular comorbidities and serves as an independent predictor of CVD. These findings may highlight the need for tailored management strategies based on specific clinical presentations.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies